Completing the Health Declaration for Viagra Connect
Using online resources, printed materials and in-store face-to-face sessions, pharmacists were trained to assess ED patients’ suitability of VC including an assessment of comorbidities and concomitant medications and to advise ED patients to consult their doctors within 6 months in order to assess any underlying health issues and the risk of misdiagnosis. This exploratory patient survey was conducted as part of the aRMM evaluation to assess patients’ experience while purchasing VC in a pharmacy without a prescription. This was achieved by knowing whether patients reported that they were assessed by a pharmacist for their suitability to receive VC and if they were advised by pharmacist to consult their doctor within 6 months of first supply. The survey also ascertained if patients reported having visited their doctor or planned to visit their doctor in the near future, being advised about the safe use of VC, potential causes of ED and lifestyle modifications by their pharmacist. This was a cross-sectional, web-based survey conducted in the UK between October 2020 and June 2021.
How to take Viagra Connect F/C 50mg Tablets
Using online resources, printed materials and in-store face-to-face sessions, pharmacists were trained to assess ED patients’ suitability of VC including an assessment of comorbidities and concomitant medications and to advise ED patients to consult their doctors within 6 months in order to assess any underlying health issues and the risk of misdiagnosis. This exploratory patient survey was conducted as part of the aRMM evaluation to assess patients’ experience while purchasing VC in a pharmacy without a prescription. This was achieved by knowing whether patients reported that they were assessed by a pharmacist for their suitability to receive VC and if they were advised by pharmacist to consult their doctor within 6 months of first supply. The survey also ascertained if patients reported having visited their doctor or planned to visit their doctor in the near future, being advised about the safe use of VC, potential causes of ED and lifestyle modifications by their pharmacist. This was a cross-sectional, web-based survey conducted in the UK between October 2020 and June 2021.
Patients’ Reported Experience with Visiting or Planning to Visit Their Doctor
A pre-testing of survey questions was conducted in a sample of 29 patients prior to the implementation of the survey. This user-testing assessed the clarity of survey questions for interest and acceptance of the polls amongst the participants, as well as the flow and ease of completing the surveys. The findings and recommendations from the survey pre-testing were incorporated into the final version and tested in two pilot surveys for further refinement.8,14 This patient survey was administered online anonymously and expected to take approximately 5 minutes to complete by the participants. The survey was conducted in select Boots pharmacy stores, independent pharmacy stores and regional multiple pharmacies. Pharmacies were invited to participate in the study based on their monthly VC sales data during the months of March, April, and May 2020. A pre-testing of survey questions was conducted in a sample of 29 patients prior to the implementation of the survey.
- Viagra Connect is an over-the-counter treatment for erectile dysfunction.
- It contains sildenafil, which improves blood flow to the penis.
- Available in pharmacies without a prescription.
- Patients should consult a pharmacist before use.
- Suitable for men aged 18 and over.
- Must be taken at least 30 minutes before activity.
This user-testing assessed the clarity of survey questions for interest and acceptance of the polls amongst the participants, as well as the flow and ease of completing the surveys. The findings and recommendations from the survey pre-testing were incorporated into the final version and tested in two pilot surveys for further refinement.8,14 This patient survey was administered online anonymously and expected to take approximately 5 minutes to complete by the participants. The survey was conducted in select Boots pharmacy stores, independent pharmacy stores and regional multiple pharmacies.
| Aspect | Description | Regulation/Standard |
|---|---|---|
| Data Encryption | All personal data encrypted during transmission | GDPR, HIPAA (if applicable) |
| Data Storage | Secure storage with restricted access | Data protection laws |
| User Consent | Users must agree to terms before submitting form | Legal requirement |
| Privacy Policy | Outlines data usage and user rights | Available on the website |
Pharmacies were invited to participate in the study based on their monthly VC sales data during the months of March, April, and May 2020. Also, Pharmacies throughout the UK selected, to maximize patient representativeness. All those patients who purchased VC from the participating pharmacies, received an invitation to partake in the survey.
- The product is approved by health regulatory authorities.
- It can be purchased online or in-store at pharmacies.
- Not suitable for women or individuals under 18.
- Levitra and Cialis are alternative ED medications.
- Combining with certain drugs can cause serious side effects.
- Follow the recommended dosage strictly.
Pharmacists distributed survey invitation leaflets to all the patients during the survey period, according to a standard script. The recruitment of patients was carried out by the pharmacist at the point of supply of VC. The invitation leaflet had details regarding website address, introduction, and purpose of the survey, how and to whom the data would be reported, and the measures taken to preserve their confidentiality. To begin with, screening questions were asked to determine if patients were eligible to participate in the study and those who met the inclusion criteria were allowed to complete the full survey.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 50mg | 180 + 8 Pills | 158.82€ 151.26€ | |
| Viagra Generic | 200mg | 90 + 6 Pills | 170.79€ 162.66€ | |
| Viagra Soft Tabs | 100mg | 180 + 10 Pills | 314.95€ 299.95€ | |
| Viagra Generic | 50mg | 20 Pills | 40.52€ 38.59€ | |
| Viagra Super Active | 100mg | 30 + 6 Pills | 64.09€ 61.04€ | |
| Viagra Soft Tabs | 100mg | 90 + 6 Pills | 205.31€ 195.53€ | |
| Viagra Soft Tabs | 100mg | 20 Pills | 62.99€ 59.99€ | |
| Viagra Soft Tabs | 100mg | 60 + 6 Pills | 152.94€ 145.66€ | |
| Viagra Soft Tabs | 100mg | 120 + 8 Pills | 232.21€ 221.15€ | |
| Viagra Professional | 100mg | 180 + 4 Pills | 337.30€ 321.24€ | |
| Viagra Original | 100mg | 92 + 4 Pills | 362.88€ 345.60€ | |
| Viagra Generic | 200mg | 120 + 8 Pills | 204.80€ 195.05€ | |
| Viagra Original | 100mg | 14 + 2 Pills | 89.03€ 84.79€ | |
| Viagra Original | 100mg | 12 Pills | 72.54€ 69.09€ | |
| Viagra Generic | 200mg | 20 Pills | 61.69€ 58.75€ | |
| Viagra Oral Jelly | 100mg | 90 + 8 Sachets | 258.02€ 245.73€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ |
Patients who completed the survey were offered a small voluntary monetary compensation of £25.00 to compensate for the time and effort taken to complete the survey. To receive payment, the patients were required to provide their consent to share their billing address. This step helped to minimize the risk of duplicated (ie, more than one) surveys taken by one patient. Male patients who were willing and consented to participate in this self-administered survey and reported that they purchased at least one supply of VC from the pharmacist for their own use were included in the study. Patients who reported that they or an immediate family member were currently employed with Pfizer, Upjohn, United BioSource (UBC, the survey vendor) or the UK Medicines and Healthcare products Regulatory Agency (MHRA) were excluded from the study. The survey included questions/statements that inquired about the patient’s experience at the point of VC supply in the pharmacy, including whether they were: Assessed for suitability for VC (eg, for cardiovascular and other health conditions), Advised by a pharmacist to consult their doctor within 6 months of first supply, Visited their doctor or planned to visit their doctor very soon, Advised by their pharmacist about the safe use of VC, and Advised by their pharmacist about potential causes of ED and offered lifestyle advice. Screening questions (ie, consent, gender, patient, or family member employed by Pfizer, Upjohn, UBC or UK MHRA, purchase of VC and for whom). Pharmacy and pharmacist characteristics (ie, urban vs rural and chain vs independent pharmacy; gender of the pharmacist). Patient characteristics (ie, age, confirmation of ED symptoms, history of prescribed ED medications).
- Education on safe use is essential for users.
- Proper storage ensures medication potency.
- Keep out of reach of children.
- Be aware of possible drug interactions.
- Medication should be used only under guidance.
- Regular consultation can prevent complications.
Patient’s experience when requesting VC for the first time (ie, when was the first purchase of VC, the types of questions that the pharmacist asked a patient, type of counselling received from the pharmacist, whether the patients were advised to contact their doctor, receipt of a patient record tear-off slip from a pharmacist, how comfortable the patient was with counselling from the pharmacist). Patient’s experience with or intention to see, a doctor (ie, has a patient seen a doctor, or intends to consult a doctor in the near future). Source of patient’s knowledge about VC. A structured and self-administered questionnaire comprising of close-ended questions or statements with multiple response choices was used to collect the survey data. The survey was designed to be completed voluntarily and was programmed to encrypt all identifiable information and respondent identifiers, which were stored separately within the database. Personal identifiable information of the participants was stored separately and only were used for processing the respondents’ honorarium, where applicable. Each participant was randomly assigned a unique code to access the survey.
Lactulose Oral Solution 3.3g/5ml - 500ml
Patients who reported that they or an immediate family member were currently employed with Pfizer, Upjohn, United BioSource (UBC, the survey vendor) or the UK Medicines and Healthcare products Regulatory Agency (MHRA) were excluded from the study. The survey included questions/statements that inquired about the patient’s experience at the point of VC supply in the pharmacy, including whether they were: Assessed for suitability for VC (eg, for cardiovascular and other health conditions), Advised by a pharmacist to consult their doctor within 6 months of first supply, Visited their doctor or planned to visit their doctor very soon, Advised by their pharmacist about the safe use of VC, and Advised by their pharmacist about potential causes of ED and offered lifestyle advice. Screening questions (ie, consent, gender, patient, or family member employed by Pfizer, Upjohn, UBC or UK MHRA, purchase of VC and for whom). Pharmacy and pharmacist characteristics (ie, urban vs rural and chain vs independent pharmacy; gender of the pharmacist). Patient characteristics (ie, age, confirmation of ED symptoms, history of prescribed ED medications).
Study Variables
Patient’s experience when requesting VC for the first time (ie, when was the first purchase of VC, the types of questions that the pharmacist asked a patient, type of counselling received from the pharmacist, whether the patients were advised to contact their doctor, receipt of a patient record tear-off slip from a pharmacist, how comfortable the patient was with counselling from the pharmacist). Patient’s experience with or intention to see, a doctor (ie, has a patient seen a doctor, or intends to consult a doctor in the near future). Source of patient’s knowledge about VC. A structured and self-administered questionnaire comprising of close-ended questions or statements with multiple response choices was used to collect the survey data. The survey was designed to be completed voluntarily and was programmed to encrypt all identifiable information and respondent identifiers, which were stored separately within the database. This code was deactivated upon its use to prevent the code from being used repeatedly and complete the survey multiple times.
- The drug improves quality of life for many men with ED.
- It is part of a broader treatment approach, including counseling.
- Mental health can impact erectile function.
- Lifestyle changes can enhance medication effectiveness.
- Support groups may provide additional help.
- Consult your doctor if ED persists despite treatment.
Once the participant started the survey, it had to be completed and there was no opportunity to return to the survey later. The participant was permanently logged out pink viagra of the survey following 30 minutes of inactivity. Once the survey was completed, it was not possible to link the survey to an individual.
What is Mounjaro
Depending on the answers to the screening questions, survey participation was either terminated or continued. If ineligible, the participant was immediately notified with a “thank you” message that survey participation has ended. In this study, the aim was to obtain at least 300 completed surveys, which considers statistical and practical considerations of participation in this type of surveys. With a sample size of 300, the statistical precision around the estimate will be ±5.8%. The precision of the estimate calculations is based on the assumption that 50% of the participating patients report that they were assessed by a pharmacist for suitability for Viagra Connect and 50% report that they were advised by a pharmacist to consult their doctor.
Online survey
Basing the sample size estimate on this assumption that 50% patients reporting the desired outcome related to the primary objectives is the most conservative approach, since either a higher or lower percentage than 50% will lead to higher statistical precision. Data collected from the survey were summarized with descriptive statistics and no statistical comparisons were made using hypothesis testing. Patient responses were considered for frequency distributions with 95% confidence intervals (CIs) and survey data were stratified based on pharmacy and patient characteristics. Subgroup analyses for participants responses to the questions regarding pharmacists’ assessment of their suitability for VC, and advice on appropriate use of VC and on their need to see doctors were performed by the stratification of the following variables: • Age-group (18–40 years, 41–60 years, or 61 years or older); • Having symptoms of ED (Yes or No); • Having been prescribed sildenafil or other ED medication by the doctor (Yes or No); • Type of pharmacy (chain pharmacy, or independent pharmacy); • Survey completion status (completers, or non-completers); • Whether the pharmacists asked the patient if he has ED (Yes or No). A total of 5144 pharmacies, covering a wide geography of UK, were invited to participate in this study. The participants did not have to actively decline to complete the survey. Therefore, the study operator had no ability to track which participants actively decided to not complete the survey. This survey design encouraged participation and answering honestly by ensuring that the responses were completely anonymous. Following a question to obtain the patient’s consent to participate, the survey included a screening module with questions to confirm eligibility. Depending on the answers to the screening questions, survey participation was either terminated or continued.
What does Lamisil AT 1% Spray contain?
This included 1552 (30%) of Boots Pharmacies, 2040 (40%) of independent pharmacies and 1552 (30%) of regional multiple pharmacies. Of these, 430 pharmacies agreed to participate in the study. For enrollment of Participants in the survey, 33,690 patient survey invitation leaflets were sent to 130 registered pharmacies between 18 September 2020 and 08 October 2020 in wave one (ie, 1st batch of mailing) and 58,258 invitation leaflets were sent to 300 registered pharmacies between 17 May 2020 and 15 June 2021 in wave two (ie, 2nd batch of mailing). Wave two mailing was added because the number of participants did not reach the 300 targets in wave one. A total of 412 patients were screened for eligibility, of which 73.5% (n = 303) of them met the inclusion criteria. If ineligible, the participant was immediately notified with a “thank you” message that survey participation has ended. In this study, the aim was to obtain at least 300 completed surveys, which considers statistical and practical considerations of participation in this type of surveys.
Cialis Together 10mg - 4 Tablets
Also, Pharmacies throughout the UK selected, to maximize patient representativeness. All those patients who purchased VC from the participating pharmacies, received an invitation to partake in the survey. Pharmacists distributed survey invitation leaflets to all the patients during the survey period, according to a standard script. The recruitment of patients was carried out by the pharmacist at the point of supply of VC. The invitation leaflet had details regarding website address, introduction, and purpose of the survey, how and to whom the data would be reported, and the measures taken to preserve their confidentiality.
Who Can Use Viagra Connect?
To begin with, screening questions were asked to determine if patients were eligible to participate in the study and those who met the inclusion criteria were allowed to complete the full survey. Patients who completed the survey were offered a small voluntary monetary compensation of £25.00 to compensate for the time and effort taken to complete the survey. To receive payment, the patients were required to provide their consent to share their billing address. This step helped to minimize the risk of duplicated (ie, more than one) surveys taken by one patient. Male patients who were willing and consented to participate in this self-administered survey and reported that they purchased at least one supply of VC from the pharmacist for their own use were included in the study. With a sample size of 300, the statistical precision around the estimate will be ±5.8%. The precision of the estimate calculations is based on the assumption that 50% of the participating patients report that they were assessed by a pharmacist for suitability for Viagra Connect and 50% report that they were advised by a pharmacist to consult their doctor. Basing the sample size estimate on this assumption that 50% patients reporting the desired outcome related to the primary objectives is the most conservative approach, since either a higher or lower percentage than 50% will lead to higher statistical precision. Data collected from the survey were summarized with descriptive statistics and no statistical comparisons were made using hypothesis testing.
What do Sildenafil 50mg Tablets contain?
Personal identifiable information of the participants was stored separately and only were used for processing the respondents’ honorarium, where applicable. Each participant was randomly assigned a unique code to access the survey. This code was deactivated upon its use to prevent the code from being used repeatedly and complete the survey multiple times. Once the participant started the survey, it had to be completed and there was no opportunity to return to the survey later. The participant was permanently logged out pink viagra of the survey following 30 minutes of inactivity.
Pharmacists’ Advice to Patients to Consult Their Doctor Within 6 Months of First Supply
Once the survey was completed, it was not possible to link the survey to an individual. The participants did not have to actively decline to complete the survey. Therefore, the study operator had no ability to track which participants actively decided to not complete the survey. This survey design encouraged participation and answering honestly by ensuring that the responses were completely anonymous. Following a question to obtain the patient’s consent to participate, the survey included a screening module with questions to confirm eligibility. Patient responses were considered for frequency distributions with 95% confidence intervals (CIs) and survey data were stratified based on pharmacy and patient characteristics.
Viagra Connect FAQs: Expert Advice for Irish Customers
About 98.0% (n = 297/303) of the study participants completed the survey while 2.0% of them (n = 6) initiated the survey but did not complete it. The average time to complete this web-based survey was 4.2 minutes, with 72.1% (n = 214) of the participants completed the survey in less than 5 minutes. Patient demographics showed that 45.5% (n = 135) and 41.4% (n = 123) of the participants were in the age group of 41–60 years and 18–40 years, respectively. Symptoms of ED was reported by 86.2% (n = 256) of the participants, 13.8% (n = 41) reported that they were prescribed sildenafil or other ED medication by their doctor and 28.3% (n = 84) reported first purchase of VC from their pharmacist within the last month. Subgroup analyses for participants responses to the questions regarding pharmacists’ assessment of their suitability for VC, and advice on appropriate use of VC and on their need to see doctors were performed by the stratification of the following variables: • Age-group (18–40 years, 41–60 years, or 61 years or older); • Having symptoms of ED (Yes or No); • Having been prescribed sildenafil or other ED medication by the doctor (Yes or No); • Type of pharmacy (chain pharmacy, or independent pharmacy); • Survey completion status (completers, or non-completers); • Whether the pharmacists asked the patient if he has ED (Yes or No). A total of 5144 pharmacies, covering a wide geography of UK, were invited to participate in this study. This included 1552 (30%) of Boots Pharmacies, 2040 (40%) of independent pharmacies and 1552 (30%) of regional multiple pharmacies. Of these, 430 pharmacies agreed to participate in the study. For enrollment of Participants in the survey, 33,690 patient survey invitation leaflets were sent to 130 registered pharmacies between 18 September 2020 and 08 October 2020 in wave one (ie, 1st batch of mailing) and 58,258 invitation leaflets were sent to 300 registered pharmacies between 17 May 2020 and 15 June 2021 in wave two (ie, 2nd batch of mailing).
| Question | Answer | Notes |
|---|---|---|
| Is Viagra Connect available over the counter? | Yes, in select pharmacies and online | Age restriction applies |
| How quickly does it work? | Typically within 30-60 minutes | Varies by individual |
| Are there any side effects? | Yes, includes headache, flushing, nasal congestion | Consult a healthcare provider before use |
| Can I take it with other medications? | Not advised without doctor approval | Possible drug interactions |
Wave two mailing was added because the number of participants did not reach the 300 targets in wave one. A total of 412 patients were screened for eligibility, of which 73.5% (n = 303) of them met the inclusion criteria. About 98.0% (n = 297/303) of the study participants completed the survey while 2.0% of them (n = 6) initiated the survey but did not complete it. The average time to complete this web-based survey was 4.2 minutes, with 72.1% (n = 214) of the participants completed the survey in less than 5 minutes. Patient demographics showed that 45.5% (n = 135) and 41.4% (n = 123) of the participants were in the age group of 41–60 years and 18–40 years, respectively. Symptoms of ED was reported by 86.2% (n = 256) of the participants, 13.8% (n = 41) reported that they were prescribed sildenafil or other ED medication by their doctor and 28.3% (n = 84) reported first purchase of VC from their pharmacist within the last month.